Literature DB >> 20215612

Building comparative efficacy and tolerability into the FDA approval process.

Alec B O'Connor1.   

Abstract

Mesh:

Year:  2010        PMID: 20215612     DOI: 10.1001/jama.2010.257

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Challenges of translating basic research into therapeutics: resveratrol as an example.

Authors:  James M Smoliga; Ole Vang; Joseph A Baur
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-11       Impact factor: 6.053

2.  Outcome reporting among drug trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  Ann Intern Med       Date:  2010-08-03       Impact factor: 25.391

3.  Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.

Authors:  Florence T Bourgeois; Karen L Olson; Annapurna Poduri; Kenneth D Mandl
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 4.  Comparative effectiveness and implementation research: directions for neurology.

Authors:  Barbara G Vickrey; Deborah Hirtz; Salina Waddy; Eric M Cheng; S Claiborne Johnston
Journal:  Ann Neurol       Date:  2012-06       Impact factor: 10.422

5.  Enhancing prescription drug innovation and adoption.

Authors:  G Caleb Alexander; Alec B O'Connor; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

6.  Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

7.  Assessment of the therapeutic value of new medicines marketed in Australia.

Authors:  Agnes I Vitry; Ng Huah Shin; Pauline Vitre
Journal:  J Pharm Policy Pract       Date:  2013-06-13

8.  Response to Michael Wonder's comments on the article 'Assessment of the therapeutic value of new medicines marketed in Australia'.

Authors:  Agnes I Vitry
Journal:  J Pharm Policy Pract       Date:  2013-10-10

9.  Ethical considerations in placebo-controlled randomised clinical trials.

Authors:  Kenneth R Kaufman
Journal:  BJPsych Open       Date:  2015-06-30

10.  A new approach to psychiatric drug approval in Europe.

Authors:  Corrado Barbui; Irene Bighelli
Journal:  PLoS Med       Date:  2013-10-15       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.